Chemical activators of Tdpoz5 utilize various pathways to elevate intracellular cyclic AMP (cAMP), which is a common messenger for signaling processes that lead to the activation of proteins like Tdpoz5. Forskolin directly targets adenylyl cyclase, the enzyme responsible for converting ATP to cAMP. By enhancing cAMP production, Forskolin thereby promotes the activation of protein kinase A (PKA), which in turn can phosphorylate and activate Tdpoz5. Similarly, Isoproterenol and Salbutamol function as agonists for beta-adrenergic receptors, and Terbutaline selectively activates beta-2 adrenergic receptors. The binding of these compounds to their respective receptors results in a signaling cascade that also culminates in increased cAMP levels and subsequent activation of PKA, leading to the phosphorylation of Tdpoz5.
IBMX and Rolipram, as phosphodiesterase inhibitors, prevent the breakdown of cAMP, thus sustaining its action within the cell and prolonging the activation signal for PKA, which is essential for Tdpoz5 activation. Prostaglandins such as PGE1 and PGE2 activate E-prostanoid receptors, which follow a similar pathway involving the increase of cAMP and activation of PKA, triggering the phosphorylation and activation of Tdpoz5. Glucagon, a hormone, acts upon its receptor to similarly raise cAMP levels and activate Tdpoz5 through PKA. Epinephrine, a well-known hormone and neurotransmitter, interacts with adrenergic receptors, utilizing the same cAMP-mediated pathway to phosphorylate and thereby activate Tdpoz5. Cholera Toxin permanently activates the Gs alpha subunit of the G protein-coupled receptor, which leads to a prolonged increase in cAMP and a sustained activation signal for Tdpoz5 through PKA. Lastly, Dobutamine, a beta-1 adrenergic receptor agonist, increases cAMP concentration in the cells, thus promoting the activation of Tdpoz5 via phosphorylation by PKA. Each of these chemicals, through their unique interaction with cellular receptors or enzymes, ensures that the cAMP-PKA axis is engaged, culminating in the activation of Tdpoz5.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Agonist at beta-adrenergic receptors, increasing cAMP and activating Tdpoz5 through PKA-mediated phosphorylation. | ||||||
Salbutamol | 18559-94-9 | sc-253527 sc-253527A | 25 mg 50 mg | $94.00 $141.00 | ||
Stimulates beta-2 adrenergic receptors, raising cAMP levels and leading to Tdpoz5 activation via PKA. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $92.00 $378.00 | 2 | |
Selectively binds to beta-2 adrenergic receptors, elevating cAMP and activating Tdpoz5 through PKA. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Inhibits phosphodiesterase, preventing cAMP breakdown, thereby activating Tdpoz5 by sustained PKA action. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Phosphodiesterase inhibitor that increases cAMP levels, leading to PKA-mediated activation of Tdpoz5. | ||||||
PGE1 (Prostaglandin E1) | 745-65-3 | sc-201223 sc-201223A | 1 mg 10 mg | $31.00 $145.00 | 16 | |
Binds to E-prostanoid receptors, increasing cAMP and thus activating Tdpoz5 through PKA phosphorylation. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Interacts with E-prostanoid receptors, enhancing cAMP and activating Tdpoz5 via PKA-dependent phosphorylation. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Engages adrenergic receptors, boosting cAMP and activating Tdpoz5 through phosphorylation by PKA. | ||||||
Dobutamine | 34368-04-2 | sc-507555 | 100 mg | $295.00 | ||
Stimulates beta-1 adrenergic receptors, causing increased cAMP and activation of Tdpoz5 through PKA phosphorylation. | ||||||